| |
|
|
|
HTG Molecular Diagnostics Inc.  
|
|
1.81 -0.08 (-0.04%) |
06-21 16:00 |
|
Open: |
1.91 |
Pre close: |
1.89 |
Target:
|
2.53 
|
|
High: |
1.91 |
Low: |
1.78 |
Resistance:
|
2.16
2.42
|
|
Volume: |
197,183 |
Market Cap: |
52M |
Support:
|
1.75
1.46
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.89
|
MACD |
MACD(12,26):
|
-0.12 |
|
MA(20): |
2.07 |
Signal(12,26,9): |
-0.11 |
|
MA(100): |
2.40 |
Stochastic Oscillator |
%K(14,3):
|
25.79  |
|
MA(250): |
3.00 |
%D(3): |
23.57 |
|
Average Volume(K) |
3-Month: |
24023
|
52-Week |
High:
|
5.46 |
|
10-Days: |
19818 |
Low: |
1.75 |
|
RSI |
RSI(14):
|
33.53 |
Change(%): |
-47.1 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.577 |
Return on Equity (ttm) |
-70.0 |
Shares Out. (M) |
28.64 |
|
EPS Est. Current Year |
-2.290 |
Return on Assets (ttm) |
-22.6 |
Shares Float (M) |
23.47 |
|
EPS Est. Next Year |
-1.720 |
PEG Ratio |
0.00 |
% Held by Insiders |
7.75 |
|
EPS Est. Next Quarter |
-0.480 |
Qtrly Rev. Growth |
-23.0 |
% Held by Institutions |
51.30 |
|
Forward EPS |
-0.720 |
Gross Profit (p.s.) |
0.139 |
Shares Short (K) |
3610 |
|
Book Value (p.s.) |
0.560 |
EBITDA (p.s.) |
-0.518 |
P/E |
-3.14 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
3.23 |
|
Profit Margin |
-80.03 |
Operating Cash Flow
(M) |
-16.07 |
P/S |
71997776.00 |
|
Operating Margin |
-79.09 |
Levered Free Cash Flow
(M) |
-10.06 |
P/CF |
-3.23 |
|
|
|
|
|
|
